Dr Reddy's gets DCGI nod for cancer drug's second indication in India
The approval allows toripalimab with cisplatin and paclitaxel as first-line treatment for unresectable advanced, recurrent or metastatic ESCC in adults
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Dr Reddy's receives DCGI approval for esophageal cancer drug Zytorvi business-standard.com
